SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Cash Flow
Sinovac Biotech Ltd (SVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q4 23), "Operating Cash Flow" came in at 146 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 13 | Q2 13 | Q3 13 | Q4 13 | Q1 14 | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q4 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.6 | -3.3 | -5.4 | -5.8 | -5.8 | -5.6 | -4.8 | 7.5 | -8.2 | 0.4 | -2.8 | -9.5 | -9.5 | -6.0 | 0.1 | 0.0 | 2.5 | 2.1 | 0.0 | 58 | -5.0 | -7.9 | 13 | -8.7 | -8.7 | 9.7 | 12 | -18 | -18 | 2.4 | 14 | 481 | 481 | 9,087 | 6,265 | -808 | 358 | -1,268 | 579 | 146 | |
| 1.7 | 1.8 | 1.7 | 2.7 | 2.7 | 2.0 | 0.8 | 3.0 | 1.7 | 1.8 | 1.7 | 1.5 | 1.5 | 1.5 | 1.3 | 1.0 | 1.1 | 2.1 | 1.0 | 2.5 | 1.3 | 1.3 | 1.3 | 1.1 | 1.1 | 1.2 | 1.3 | 0.8 | 0.8 | 1.6 | 0.3 | 1.3 | 1.3 | 17 | 69 | 78 | 208 | 152 | -73 | 61 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 1.5 | – | – | 1.5 | 0.4 | 0.4 | 2.4 | 0.7 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 8.0 | 0.8 | 0.8 | – | -1.7 | -881 | -9.5 | -9.5 | -148 | – | |
| – | – | – | 0.0 | 0.0 | – | 0.3 | 2.3 | – | – | – | 1.0 | – | – | 1.5 | 0.3 | 2.1 | 2.1 | 2.5 | 2.5 | 8.2 | 5.6 | 5.7 | 5.1 | 1.7 | 5.6 | 3.6 | 6.7 | -1.7 | 3.0 | 16 | 65 | – | – | – | – | – | – | – | – | |
| -5.7 | -8.4 | -10 | -9.7 | -9.7 | -5.2 | -6.2 | 2.6 | -7.4 | -5.5 | -2.8 | -9.6 | -9.6 | 1.7 | -5.9 | -6.4 | – | -15 | -6.4 | 35 | -23 | -22 | -2.7 | -13 | -13 | -9.2 | -1.1 | -11 | -11 | 1.5 | -13 | 306 | 306 | 546 | -85 | -1,721 | -294 | -294 | 0.0 | 278 | |
| 2.2 | 0.5 | 0.8 | 2.2 | 2.2 | 3.5 | 1.6 | 3.7 | 1.8 | 1.1 | 0.5 | 3.5 | 3.5 | 1.1 | 3.6 | 4.4 | 3.4 | 6.8 | 4.4 | 5.1 | 1.5 | 1.3 | 1.8 | 0.6 | 0.6 | 5.8 | 2.4 | 3.0 | 3.0 | 33 | 33 | 58 | 58 | 444 | 307 | 289 | 21 | 269 | 15 | 53 | |
| -2.2 | -0.5 | -0.8 | -5.2 | -2.2 | -3.5 | -1.6 | -11 | -1.8 | -1.1 | -0.5 | -4.5 | -2.7 | -1.1 | -3.6 | -12 | -3.4 | -6.8 | -4.4 | -5.1 | -1.5 | -1.3 | -21 | -11 | -0.6 | -5.8 | -3.8 | -32 | 26 | -48 | -30 | -152 | -152 | -3,275 | 251 | -3,585 | -2,290 | – | -2,731 | -195 | |
| – | – | – | 0.6 | – | – | – | 0.6 | – | – | – | 0.0 | – | – | – | – | – | 122 | 178 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | 23 | 1,876 | 19 | 170 | 263 | 145 | – | |
| 0.2 | 0.3 | 0.1 | 0.3 | – | – | – | 0.6 | 0.3 | 0.3 | 0.0 | 0.2 | 0.0 | 0.8 | -0.6 | 0.1 | 0.0 | -74 | -45 | 1.7 | 0.0 | 0.0 | 85 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | -418 | -554 | -204 | – | -133 | – | |
| – | – | – | 13 | – | – | – | 1.2 | – | – | – | -25 | – | – | 8.8 | 21 | -3.4 | -3.4 | 0.6 | 0.6 | -7.0 | -3.9 | -0.9 | -7.3 | -1.3 | -2.0 | -2.0 | 2.1 | 5.9 | 18 | 14 | 536 | – | – | – | – | – | – | – | – | |
| 8.0 | 3.8 | 3.3 | 3.4 | 3.4 | -2.5 | 11 | -6.3 | -18 | 2.3 | -6.2 | 11 | 11 | -5.0 | 8.8 | 14 | -3.3 | -6.7 | 14 | 5.3 | -6.5 | -3.0 | 86 | -1.1 | -1.1 | 0.1 | 0.0 | 6.6 | 6.6 | 21 | 23 | 542 | 542 | -30 | -1,867 | 12 | -334 | -827 | -802 | -293 | |
| 0.3 | 0.5 | -3.0 | -5.6 | -5.6 | -12 | 4.7 | -2.8 | -28 | 1.7 | -10 | -1.3 | -1.3 | -13 | 5.1 | 8.1 | -3.7 | -11 | 8.1 | 58 | -11 | -17 | 76 | -9.1 | -9.1 | 2.6 | 5.0 | 13 | 13 | -24 | 9.2 | 896 | 896 | 6,698 | 4,763 | -4,753 | 97 | 3,236 | -163 | -371 | |
| -7.7 | -3.8 | -6.1 | -8.0 | -8.0 | -9.1 | -6.4 | 3.8 | -10.0 | -0.6 | -3.4 | -13 | -13 | -7.1 | -3.5 | -4.4 | – | -4.7 | -4.4 | 53 | -6.5 | -9.3 | 11 | -9.3 | -9.3 | 3.9 | 9.2 | -21 | -21 | -31 | -19 | 423 | 423 | 8,643 | 5,958 | -1,097 | 337 | -1,537 | 564 | 93 |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.